秘鲁首个乙型肝炎疫苗试点项目实施前后肝细胞癌、肝硬化和暴发性肝炎死亡负担趋势:死亡证明数据分析
研究基于阿班凯市死亡证明数据,比较秘鲁1991年在高流行区阿班凯省实施首个乙型肝炎疫苗试点项目前后(1960-1990年与1991-2012年)肝细胞癌、肝硬化和暴发性肝炎的死亡率趋势。结果显示项目实施后三种疾病总体死亡率均下降,5-14岁儿童中肝硬化和暴发性肝炎归因死亡绝对数减少。
要点
- 疫苗项目实施后,肝细胞癌总体死亡率从9.20降至3.30/10万(95%CI 1.28-10.48%,P<0.014)。
- 肝硬化总体死亡率从16.0降至6.3/10万(95%CI 3.20-16.10%,P<0.004)。
- 暴发性肝炎总体死亡率从34.80降至1.28/10万(95%CI 16.70-50.30%,P<0.001)。
核心结论
- 乙型肝炎疫苗项目实施后,乙型肝炎相关肝病死亡率下降,尤其是15岁以下儿童的肝硬化和暴发性肝炎死亡率降低。
研究设计与样本
- 研究基于阿班凯市死亡证明数据,比较疫苗接种项目实施前(1960-1990年)与实施后(1991-2012年)的死亡率趋势。
主要发现
- 肝细胞癌总体死亡率从9.20/10万降至3.30/10万(95%CI 1.28-10.48%,P<0.014)。
- 肝硬化总体死亡率从16.0/10万降至6.3/10万(95%CI 3.20-16.10%,P<0.004)。
- 暴发性肝炎总体死亡率从34.80/10万降至1.28/10万(95%CI 16.70-50.30%,P<0.001)。
- 5-14岁儿童中,肝硬化归因死亡绝对数从10例(8.80%)降至0例(0.0%)(P<0.001)。
- 5-14岁儿童中,暴发性肝炎归因死亡绝对数从83例(40.0%)降至5例(19.20%)(P<0.026)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The first pilot vaccination program against hepatitis B in Peru was implemented in the hyperendemic Abancay province in 1991. To assess the impact of vaccination on mortality rates of hepatitis B-related hepatocellular carcinoma (HCC), cirrhosis, and fulminant hepatitis, we compared mortality trends before (1960-1990) and after (1991-2012) roll-out of the vaccination program, using death certificate data from the Municipalidad Provincial de Abancay. Our results showed that, following program roll-out, the overall mortality rates (per 100,000 population) decreased from 9.20 to 3.30 for HCC (95% CI, 1.28-10.48%; P<0.014), from 16.0 to 6.3 for cirrhosis (95% CI, 3.20-16.10%; P<0.004), and from 34.80 to 1.28 for fulminant hepatitis (95% CI, 16.70-50.30%; P<0.001). The absolute number of deaths attributable to cirrhosis (10 [8.80%] vs. 0.0%; P<0.001) and fulminant hepatitis (83 [40.0%] vs. 5 [19.20%]; P<0.026) decreased in 5-14-year-old children following vaccination. These findings showed reduced mortality rates of hepatitis B-related liver diseases, particularly cirrhosis and fulminant hepatitis in children under 15years, following implementation of the vaccination program against hepatitis B.
引用
- Ramírez-Soto MC, Ortega-Cáceres G, Cabezas C, et al. Trends in mortality burden of hepatocellular carcinoma, cirrhosis, and fulminant hepatitis before and after roll-out of the first pilot vaccination program against hepatitis B in Peru: An analysis of death certificate data. Vaccine. 2017. PMID: 28602606. doi:10.1016/j.vaccine.2017.05.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。